skip to Main Content

New Yearly Osteoporosis Drug Launched

The New England Journal of Medicine has published the results of a new study that says that a simple annual injection has the potential to significantly reduce the risk of bone fractures in elderly women.

The study which was funded by the manufacturer, found that Reclast (produced by Novartis Pharma) was able to reduce the incidences of spine, hip and non-spine fractures as well. When compared to a placebo, there was an increase in bone mineral density as well.

The majority of women that are diagnosed with osteoporosis are treated with drugs called Biophosphanates which are used to slow down the body’s ability to reabsorb calcium from bone.  However, according to Dennis Black, compliance is not consistent and often results in patients not taking the full dose over the course of a year.

In the study women receiving the injections had a 70% reduction in risk of spine fractures.  The study involved 7,700 women who were aged 65 to 89 in 27 different countries and all women had been diagnosed with post menopausal osteoporosis.

Linda Parkinson-Hardman

Transformational counsellor, coach and women's health advocate. Professionally I'm an information scientist who specialises in change management, culture change and adoption of digital technologies in large enterprises and organisations. I am a writer and author of nine books to date, and I've edited a further seven; phew what a lot for a Thursday afternoon :-)

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back To Top
%d bloggers like this: